Skip to main content
Fig. 3 | BMC Geriatrics

Fig. 3

From: Factors associated with mortality in hospitalised, non-severe, older COVID-19 patients – the role of sarcopenia and frailty assessment

Fig. 3

Risk of death during COVID-19 infection as a function of chronic medications. Adjusted for sex and age. *OR, odds ratio, 95% CI, 95% confidence interval; PPI, proton-pump inhibitors; NSAID, non-steroidal anti-inflammatory drugs; ANTI_DEP, antidepressants; NEUROL, neuroleptics; SULF_UREA, sulphonylureas; NOAC, non-vitamin K antagonist oral anticoagulants; VKA, vitamin K antagonists; ASA, aspirin; STAT, statins; ABL, alfa-blockers; MRA, mineralocorticoid receptor antagonists; CCB, calcium channel blockers; DIU, diuretics; BBL, beta-blockers; ARB, Angiotensin receptor blocker; ACE-I, angiotensin-converting enzyme inhibitors

Back to article page

BMC Geriatrics

ISSN: 1471-2318

Contact us